Clinical Research Facility

Jenkintown, Pennsylvania 19046

We've found

2 trials

at this facility

Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis

Status: Enrolling, Phase III
Updated: 2/7/2017

from

Jenkintown, PA

Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Jenkintown, PA

Use our guide to learn which trials are right for you!